Reality Check: Biorepository & Clinical Research Laboratory Workflows in Pakistan
Biorepository and clinical research laboratories in Pakistan operate in a long-horizon stewardship model, where responsibility for a sample extends far beyond collection and initial testing. While SOPs describe controlled workflows, real-world operations are shaped by multi-year studies, overlapping protocols, storage constraints, and evolving ethical requirements. This reality check explains how biorepositories actually function day to day.
Sample Inflow from Multiple Clinical and Field Sources
Biorepositories receive samples from:
- Hospitals and diagnostic laboratories
- Clinical trial sites
- Community and field collection programs
- Academic research projects
In practice:
- Samples arrive in batches rather than continuously
- Metadata completeness varies by source
- Initial documentation quality is inconsistent
As repositories grow, early-stage documentation gaps propagate downstream, making long-term traceability difficult.
Processing, Aliquoting, and Relabeling Under Volume Pressure
Biospecimen often require:
- Centrifugation and separation
- Aliquoting into multiple vials
- Relabeling for long-term storage
Operational realities include:
- Manual labeling during aliquoting
- High repetition tasks increasing error risk
- Weak linkage between parent samples and aliquots
Aliquoting is one of the highest-risk stages for traceability loss.
Long-Term Storage Across Complex Physical Structures
Samples are stored across:
- Ultra-low freezers
- Liquid nitrogen tanks
- Cold rooms and backup units
In practice:
- Location tracking relies on spreadsheets
- Freezer reorganizations are common
- Temporary relocations are poorly documented
Over time, location drift becomes a significant operational risk.
Sample Access, Withdrawal, and Secondary Use
Researchers request samples for:
- Secondary analysis
- Collaborative studies
- Validation or replication
Common challenges include:
- Manual approval tracking
- Unclear linkage to consent scope
- Unrecorded partial usage or depletion
This creates ethical and audit exposure.
Documentation Growth Without Structural Control
Biorepositories generate:
- Sample inventories
- Consent forms
- Ethics approvals
- Temperature logs
- Access records
These are often stored across:
- Research offices
- Lab computers
- Shared drives
Reconstructing a full sample history years later is time-consuming and uncertain.
Budget Constraints Without Validation Planning
Operational reality
Pharma LIMS implementation requires validation, training, and ongoing governance.
Why timing matters
Implementing without validation planning compromises regulatory acceptance.
Risk of premature implementation
Partial or non-validated systems that increase regulatory risk.
Biorepositories in Pakistan function through manual diligence rather than enforced governance. As sample counts, study overlap, and storage duration increase, this operating model becomes fragile. Understanding this reality is essential before analyzing failure points and regulatory expectations.